Periarticular corticosteroid treatment of the sacroiliac joint

Current Rheumatology Reviews

Volumn 3, Issue 2, 2007, Pages 155-157

  Luukkainen, Reijo ^a  

^a SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Low back pain; Periarticular corticosteroids; Sacroiliac joint; Spondylarthropathy

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LIDOCAINE; METHYLPREDNISOLONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; DRUG TREATMENT FAILURE; EXERCISE TEST; FOLLOW UP; HUMAN; LOW BACK PAIN; PAIN ASSESSMENT; PERIARTICULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SACROILIAC JOINT; SACROILIITIS; SPONDYLOARTHROPATHY; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

EID: 34248634313     PISSN: 15733971     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339707780619449     Document Type: Review

References (30)

1. Kelsey JL, White A. Epidemiology and impact of low back pain. Spine 1980; 5: 133-42.
2. Dixon A. Progress and problems in back pain research. Rheumatol Rehabil 1973; 12: 165-75.
3. Indal A. Low back pain: diagnosis, treatment and prognosis. Scand J Rheumatol 2004; 33: 199-209.
4. Waddel G. A new model for the treatment of low back pain. Spine 1987; 12: 632-44.
5. Wright V, Moll JMH (eds): The seronegative spondylarthritides - a new concept. In Seronegative Polyarthritis. Amsterdam, North Holland, 1976 pp 29-80.
6. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Surrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973: 1: 904-7.
7. Brewerton DA, Caffrey M, Nicholls A, Walters D, Oates JK, James DC. Reiter's disease and HL-A 27. Lancet 1973; 2: 996-8.
8. Dougados M, van der Linden S, Juhlin R, et al. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991 a; 34: 1218-27.
9. Hoppenfeld S: Physical Examination of the Spine and Extremities. New York, Appleton-Century-Crofts, 1976: 237-63.
10. Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis: results of a 10-year follow up. J Rheumatol 1988; 7: 1109-14.
11. Maksymowych WP, Lambert RGW. Magnetic resonance imaging of the sacroiliac joints. J Clin Rheumatol 2000; 6: 305-8.
12. Braun J, Sieper J, Bollow M. Imaging of sacroiliitis. Clin Rheumatol 2000; 30: 51-7.
13. Leirisalo-Repo M. Prognosis, course of disease, and treatment of the spondylarthropathies. Rheum Dis Clin North Am 1998; 24: 737-51
14. Braun J, Baraliakos X, Brandt J, Sieper J. Therapy of ankylosing spondylitis. Part II: Biological therapies in the spondyloarthritides. Scand J Rheumatol 2005; 34: 178-90.
15. Strender L-E, Sjöblom A, Sundell K, Ludvig R, Taube A. Interexaminer reliability in physical examination of patients with low back pain. Spine 1997; 22: 814-20.
16. Tuder van MW, Assendelft WJJ, Koes BW, Bouter LM. Spinal radiographic findings and nonspecific low back pain. A systematic review of observational studies. Spine 1997; 22: 121-37.
17. Boden SD, Davis DO, Dina TS, Patronas NJ, Wiesel SW. Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg 1990; 72A: 403-8.
18. Berry H, Bloom B, Hamilton EBD, Swinson DR. Naproxen sodium, diflunisal, and placebo in the treatment of chronic back pain. Ann Rheum Dis 1982; 41: 129-32.
19. Elenbaas JK. Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm 1980; 37: 1313-22.
20. Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for lowback pain. Spine 1989; 14: 962-4.
21. Fritz J, König CW, Gunaydin I, et al. Magnetresonanzgesteuerte Kortikosteroid-Infiltration der Sakroiliakalgelenke: Schmerztherapie der Sakroiliitis bei Patienten mit Spondylitis ankylosans. Röfo 2005; 177: 555-63.
22. Hanly JG, Mitchell M, MacMillan L, Mosher D, Sutton E. Efficacy of sacroiliac corticosteroid injections in patients with inflammatory spondyloarthropathy: results of a 6 month controlled study. J Rheumatol 2000; 27: 719-22.
23. Pereira PL, Gunaydin I, Duda SH, et al. Corticosteroid injections of the sacroiliac joint during magnetic resonance: preliminary results. J Radiol 2000; 81: 223-6.
24. Maugars Y, Mathis C, Berthelot JM, Charlier C, Prost A. Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol 1996; 35: 767-70.
25. Bollow M, Braun J, Taupitz M, et al. CT-guided intra-articular corticosteroid injection into the sacroiliac joints in patients with spondyloartropathy: indication and follow-up with contrast-enchanced MRI. J Comput Assist Tomogr 1996; 20: 512-21.
26. Braun J Bollow M, Seyrekbasan F, et al. Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondylarthropathy with sacroiliitis: Clinical outcome and follow-up by dynamic magnetic resonance imaging. J Rheumatol 1996; 23: 659-64.
27. Maugars Y, Mathis C, Vilon P, Prost A. Corticosteroid injection of the sacroiliac joint in patients with seronegative spondylarthropathy. Arthritis Rheum 1992; 35: 564-8.
28. Kissling RO. Zur Arthrographie des Iliosacralgelenks. Z Rheumatol 1992; 51: 183-7.
29. Luukkainen R, Nissilä M, Asikainen E, et al. Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy. Clin Exp Rheumatol 1999; 17: 88-90.
30. Luukkainen RK, Wennerstrand PV, Kautiainen HH, Sanila MT, Asikainen EL. Efficacy of periarticular corticosteroid treatment of the sacroiliac joint in non-spondylarthropathic patients with chronic low back pain in the region of the sacroiliac joint. Clin Exp Rheumatol 2002; 20: 52-4.